Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,154
Closed -$5.8K 2166
2025
Q1
$5.8K Buy
3,154
+1,140
+57% +$3.99K ﹤0.01% 1292
2024
Q4
$6.04K Sell
2,014
-744
-27% -$2.7K ﹤0.01% 1475
2024
Q3
$10.4K Buy
2,758
+1,277
+86% +$5.56K ﹤0.01% 2583
2024
Q2
$6.99K Buy
+1,481
New +$9.23K ﹤0.01% 2845
2023
Q2
Sell
-57
Closed -$4.03K 3435
2023
Q1
$4.03K Sell
57
-116
-67% -$10.8K ﹤0.01% 2541
2022
Q4
$14.1K Buy
+173
New +$17.4K ﹤0.01% 2313
2022
Q3
Sell
-36
Closed -$6K 3186
2022
Q2
$6K Buy
+36
New +$8.53K ﹤0.01% 2102
2022
Q1
Sell
-89
Closed -$35K 2586
2021
Q4
$35K Buy
89
+55
+162% +$32K ﹤0.01% 1332
2021
Q3
$26K Sell
34
-32
-48% -$26.8K ﹤0.01% 1446
2021
Q2
$68K Buy
+66
New +$79K ﹤0.01% 1376

Other funds holding YCBD

Two Sigma Securities's YCBD Position: Q2 2025 in Review

Two Sigma Securities sold out of cbdMD (YCBD) in Q2 2025, closing a stake of 3,154 shares — an estimated $5.8K sold.

Two Sigma Securities first reported a position in YCBD in Q2 2021 and held it in 10 quarters. The position peaked at $68K in Q2 2021. 19 funds tracked by Wall St. Rank hold YCBD as of Q2 2025.

  • Two Sigma Securities reported no remaining cbdMD position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 3,154 cbdMD shares in Q2 2025, an estimated $5.8K.
  • Two Sigma Securities first reported a position in cbdMD in Q2 2021 and held it in 10 quarters.
  • Two Sigma Securities's cbdMD position peaked at $68K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held cbdMD as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.